Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | Cardiovascular Diabetology

Figure 2

From: Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat

Figure 2

Histological quantification of fibrosis (expressed as per cent of total areas) in control and ZDF rats. ZDF rats were untreated (ZDF) or received fenofibrate (ZDF+F) or metformin (ZDF+M) after the first metabolic investigation at the age of 7 weeks. These parameters were measured only in rats sacrificed for tissue sampling (n = 5 for each group), therefore they were measured at 7 weeks only in a group of control and ZDF rats. * p < 0.05 vs the corresponding control group; € p < 0.05 vs the 7 week value of the group; $ p < 0.05 vs the corresponding untreated ZDF group.

Back to article page